Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引：14

作者：

Pereyra-Rodriguez, J. J. ^{[1
,17
]}

Herranz, P. ^{[2
]}

Figueras-Nart, I ^{[3
]}

Perez, B. ^{[4
]}

Elosua, M. ^{[5
]}

Munera-Campos, M. ^{[6
]}

Melgosa-Ramos, J. ^{[7
]}

Zaragoza, V ^{[8
]}

Silvestre, J. F. ^{[9
]}

Campos-Dominguez, M. ^{[10
]}

Guilabert, A. ^{[11
]}

Miquel, J. ^{[12
]}

Alcantara-Luna, S. ^{[13
]}

de la Cueva, P. ^{[14
]}

Serra-Baldrich, E. ^{[15
]}

Armario-Hita, J. C. ^{[16
]}

Rodriguez, Jose Juan Pereyra

机构：

[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain

[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain

[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain

[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain

[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain

[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain

[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain

[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain

[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain

[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain

[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain

[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain

[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain

[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain

[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain

[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain

[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2023年 / 33卷 / 03期

关键词：

Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;

D O I：

10.18176/jiaci.0831

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：211 / 213

页数：3

共 50 条

[21] Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis [J].

Wood, Hannah ;

Chandler, Antoinette ;

Nezamololama, Novin ;

Papp, Kim ;

Gooderham, Melinda J. .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) :746-754

[22] Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis [J].

Le, Michelle ;

Berman-Rosa, Melissa ;

Ghazawi, Feras M. ;

Bourcier, Marc ;

Fiorillo, Loretta ;

Gooderham, Melinda ;

Guenther, Lyn ;

Hanna, Sameh ;

Hong, H. Chih-Ho ;

Landells, Ian ;

Lansang, Perla ;

Marcoux, Danielle ;

Wiseman, Marni C. ;

Yeung, Jensen ;

Lynde, Charles ;

Litvinov, Ivan V. .

FRONTIERS IN MEDICINE, 2021, 8

[23] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies [J].

Guttman-Yassky, Emma ;

Thyssen, Jacob P. ;

Silverberg, Jonathan I. ;

Papp, Kim A. ;

Paller, Amy S. ;

Weidinger, Stephan ;

Hong, H. Chih-ho ;

Hendrickson, Barbara ;

Dilley, Deanne ;

Tenorio, Allan R. ;

Ladizinski, Barry ;

Chu, Alvina D. ;

Liu, John ;

Irvine, Alan D. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) :172-181

[24] Observational 24-week study to assess clinical response to upadacitinib posttrial in patients with moderate-to-severe atopic dermatitis [J].

Batalla, Ana ;

Suh-Oh, Hae Jin ;

Hernandez, Gregorio Carretero ;

Miquel-Miquel, Javier ;

Botella-Estrada, Rafael ;

Martorell-Calatayud, Antonio ;

Sanz-Motilva, Virginia ;

Figueras-Nart, Ignasi ;

Florez, Angeles .

JEADV CLINICAL PRACTICE, 2023, 2 (03) :571-575

[25] Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis [J].

Chen, Qianyu ;

Cui, Lian ;

Chen, Zeyu ;

Gao, Yunlu ;

Shi, Yuling .

HELIYON, 2023, 9 (11)

[26] Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan [J].

Hagino, Teppei ;

Yoshida, Mai ;

Hamada, Risa ;

Saeki, Hidehisa ;

Fujimoto, Eita ;

Kanda, Naoko .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)

[27] Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Study [J].

Ibba, Luciano ;

Falcidia, Costanza ;

Di Giulio, Sara ;

Bianco, Matteo ;

Valenti, Mario ;

Facheris, Paola ;

Narcisi, Alessandra ;

Costanzo, Antonio ;

Gargiulo, Luigi .

JOURNAL OF CLINICAL MEDICINE, 2025, 14 (09)

[28] Upadacitinib and Dupilumab Demonstrate Superior Efficacy in the Treatment of Adolescent Atopic Dermatitis: A Network Meta-Analysis [J].

Zhao, Zuotao ;

Peng, Chengyue ;

Liu, Lijuan ;

Zheng, Yaqi ;

Tan, Yen ;

Song, Xiaoting ;

Zhang, Peixin ;

Huang, Xiaojie ;

Zhang, Litao .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2025,

[29] The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data [J].

Napolitano, Maddalena ;

Fabbrocini, Gabriella ;

Ruggiero, Angelo ;

Marino, Vincenzo ;

Nocerino, Mariateresa ;

Patruno, Cataldo .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 :1135-1147

[30] Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice [J].

Hagino, Teppei ;

Saeki, Hidehisa ;

Fujimoto, Eita ;

Kanda, Naoko .

ANNALS OF DERMATOLOGY, 2025, 37 (02) :86-95

← 1 2 3 4 5 →